The British Medical Association has a page on its website about LGBTQ+ equality in medicine, and it is, honestly, a good page. Discrimination has no place in the profession. Trans and non-binary people have the right to access healthcare and to live their lives in dignity. The BMA has called for a total ban on conversion therapy. It has produced guidance for doctors on trans-inclusive care. It has surveyed its own members about the discrimination they face, and it has named the things that need to change: better training, visible role models, less tolerance for microaggressions, clearer reporting routes. These are not small commitments. They are exactly the kind of commitments a medical body should be making.

And then there is the Cass Review.

The BMA did commission a scientific critique of that review, produced by a Task and Finish Group with independent analysis from Health Economics and Outcomes Research Ltd. That report exists. It is linked from the same equality page. The analysts looked carefully at how the Cass team interpreted the materials and data available, and they raised serious questions about the evidential basis of the conclusions. But what happened after that report was published? The BMA's overall institutional response has not matched the force of its own equality commitments. The review's recommendations have been used to strip access to puberty blockers from trans young people across the UK. Other countries have followed. And the BMA, whose own commissioned analysis questioned those conclusions, has not stood in the gap.

There is a newer development worth naming directly. The BMA has written to NHS England disagreeing with the Government's proposals to amend the NHS constitution, and seeking confirmation that transgender patients can continue to access services that align with their identity. That letter matters. It is a clearer statement of institutional position than much of what came before, and I do not want to dismiss it. But a letter seeking confirmation is not the same as a body that has drawn a line and will not move. Trans patients are already being turned away from services. The confirmation they need is not a letter; it is access.

I think about the trans doctors and medical students who took part in the BMA's 2022 survey, carried out with the Association of LGBTQ+ Doctors and Dentists. They described discrimination from patients and from colleagues. They described workplaces that were not safe. They described the toll of being unseen. The BMA heard all of that, published it, and listed it as a priority for action. I wonder how those same people feel reading the page today, knowing that the organisation which surveyed their experiences also failed to challenge, loudly and publicly, a review that has caused measurable harm to trans young people.

This is not a contradiction you can resolve by pointing at both pages and calling it balance. Equality commitments are tested precisely at the moments when they are politically inconvenient. Calling for a conversion therapy ban is not controversial in medical circles. Producing guidance on trans-inclusive care costs nothing. Pushing back on a politically charged review whose methodology was questioned by the BMA's own commissioned analysis, when the government has already run with its conclusions and the press is hostile: that is where institutional commitment is actually measured.

The BMA's equality page says it is committed to proactively tackling discrimination in all forms. Withholding healthcare from trans young people is a form of harm. Delay is not neutral. The BMA knows this, because its own guidance says that gender dysphoria in young people requires prompt, appropriate care. The two positions cannot both be true in practice. Either the BMA believes trans young people deserve timely, evidence-based care, or it accepts an institutional review built on what its own analysts described as uncertain evidence and contested interpretation. It cannot do both and call it equality.

None of this means the BMA's equality work is worthless. The survey findings are real. The call for better LGBTQ+ medical education is real. The conversion therapy stance is real and right. The letter to NHS England is a step, and the BMA's commitment to increasing the visibility of LGBTQ+ role models, improving reporting routes, and creating space for doctors to examine their own biases without fear, these are things that matter to the people working inside the profession every day. But real equality work does not get to stop at the edges of political difficulty. The doctors and medical students the BMA surveyed did not get to stop there either. They showed up to their workplaces, faced what they faced, and kept going. The least their professional body can do is show the same consistency.